Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...

We have developed a procedure of covalently attaching nucleic acids to 1"×3" glass microscope slides. When we calculate the degree of target wash-off during hybridisation and subsequent washes (using ...

NanoMosaic's technology is designed to support upstream and downstream process development, quality control, and release testing.

PolyPEPI1018 Cancer Vaccine and TAS-102 for Patients With Advanced, Chemo-Refractory, Microsatellite-Stable Metastatic Colorectal Cancer: A Phase Ib Nonrandomized Study ctDNA was detected in 24.5% of ...